Authors/Disclosures
|
Massimiliano M. Siccoli, MD
|
No disclosure on file |
|
Gyula Acsadi, MD, FAAN
(Connecticut Children'S Medical Center/UConn)
|
Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. |
|
Roman M. Kassa, MD
(Norton Medical Group)
|
Dr. Kassa has nothing to disclose. |
|
|
No disclosure on file |
|
Nathan Tagg, MD
(Duke Eye Center)
|
Dr. Tagg has stock in Apple, Birkshire Hathaway, Medtronic. |
|
Richard S. Young, MD, FAAN
(Connecticut Childrens Specialty Group)
|
Dr. Young has nothing to disclose. |
|
Barbara E. Tettenborn, MD
(Kantonsspital St. Gallen)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Claudio L. Bassetti, MD
(Inselspital Bern)
|
No disclosure on file |